KLINMAN DENNIS M has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are UNITED CANCER RES INST, STEM CELL THERAPEUTICS CORP and MESOBLAST INT SÀRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Klinman Dennis M | 12 |
#2 | Verthelyi Daniela | 4 |
#3 | Gursel Ihsan | 3 |
#4 | Sato Takashi | 3 |
#5 | Gursel Mayda | 3 |
#6 | Zeuner Rainald | 2 |
#7 | Yamada Hiroshi | 1 |
#8 | Rouse Barry T | 1 |
#9 | Fujimoto Chiaki | 1 |
#10 | Gery Igal | 1 |
Publication | Filing date | Title |
---|---|---|
US2011077289A1 | Method of treating pneumoconiosis with oligodeoxynucleotides | |
US2009099122A1 | Use of CpG oligodeoxynucleotides to induce epithelial cell growth | |
US2004105872A1 | Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides |